Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development and ...

Owkin has partnered with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer. Takeaway Points Owkin has ...

The solution will use Owkin's data network and artificial intelligence to pre-screen for gBRCA mutations in breast cancer directly from digital pathology slides.

EOT.AI, a leader in AI-powered solutions for industrial enterprises, has announced the upcoming release of its innovative ...

Alfa Laval will release third quarter earnings on 24 October at 07:30 am CET. The conference call will start at 09:00 am CET. The conference call is hosted by Alfa Laval's President and CEO Tom Erixon ...

The growth of AI in the healthcare sector is already having real-world impacts and promises a step-change in future care.

Fractus, a leader in in antenna technology and IP licensing, announced today the successful signing of a patent licensing agreement with ADT, the market leader in connected alarm systems in the United ...

Owkin has enticed another big pharma partner with its artificial intelligence-powered clinical development platform, Bristol-Myers Squibb, which is paying $80 million upfront to tap into its ...

The Penticton public is welcome to join the Okanagan Nation Alliance for a Walk for Reconciliation Monday morning.

One of the biggest market access stories this year has been the launch of Lilly Direct (and, subsequently, PfizerForAll .) ...